Pain News and Research

Latest Pain News and Research

Home-based exercise program found ineffective for patients with peripheral artery disease

A home-based exercise program, consisting of wearable devices and telephone coaching, did not improve walking ability for patients with peripheral artery disease, according to a new Northwestern Medicine study.

24 Apr 2018

Music interventions decrease anxiety and pain of invasive surgery

Music can reduce the anxiety and pain of invasive surgery, according to an analysis of all relevant randomized controlled trials published since 1980.

24 Apr 2018

EMBL scientists develop new illumination method to manage neuropathic pain

Imagine that the movement of a single hair on your arm causes severe pain. For patients with neuropathic pain - a chronic illness affecting 7 to 8% of the European population, with no effective treatment - this can be a daily reality.

24 Apr 2018

New compound could offer pain-relieving properties without risk of addiction

Researchers at the University of Michigan have engineered a new compound that animal tests suggest could offer the pain-relieving properties of opioids such as morphine and oxycodone without the risk of addiction.

24 Apr 2018

Home-based treatment program offers robust and sustained relief for IBS patients

In the largest federally funded non-drug clinical trial for irritable bowel syndrome, patients with the most severe and persistent symptoms achieved robust and sustained relief by learning to control symptoms with minimal clinician contact. Led by University at Buffalo researchers in collaboration with colleagues at New York University and Northwestern University, the study was published online before print in Gastroenterology.

23 Apr 2018

Hacking 'drug trafficking' system could increase effectiveness of diabetes treatment

Making tiny changes to existing diabetes treatments can alter how they interact with cells, and potentially make the medicines more effective.

23 Apr 2018

Targeted radiotherapy found to be a good option for women with early breast cancer

Quality of life for women treated with a more targeted radiotherapy treatment - called accelerated partial breast irradiation - is at least as good as quality of life for women treated with standard radiotherapy, according to research presented at the ESTRO 37 conference and published simultaneously in The Lancet Oncology.

23 Apr 2018

Studies offer leads for new approaches to treat neurological problems

Technological advances have ushered in a new era of discovery in neuroscience. The Experimental Biology 2018 meeting will feature an array of research findings on the brain and nervous system.

23 Apr 2018

Study uncovers possible source of gender differences in migraines

Of the more than 38 million Americans who experience migraine headaches, 28 million are women. Compared to men, women also experience more frequent and severe migraines and don't respond as well to drug treatments.

23 Apr 2018

Innovative research could lead to new ways to treat, prevent cancer

Research into cancer can provide new insight into how this disease works and how it can be stopped. The Experimental Biology 2018 meeting will showcase innovative research that could lead to new ways to treat and prevent cancer.

23 Apr 2018

Mayo Clinic study provides valuable information about impact of pediatric anesthesia

A Mayo Clinic study of children who received one or more exposures to anesthesia before the age of 3 has provided valuable information about the potential neurological and behavioral impact of general anesthesia on very young children, according to the International Anesthesia Research Society and the Society for Pediatric Anesthesia.

20 Apr 2018

Researchers find crucial links between dopamine and avoidance behavior

Scientists at the University of Maryland School of Medicine have for the first time found direct causal links between the neurotransmitter dopamine and avoidance – behavior related to pain and fear.

20 Apr 2018

DePuy Synthes announces clinical results related to use of CORAIL Hip System Femoral Stems

DePuy Synthes, part of the Johnson & Johnson Medical Devices Companies, announced today clinical results associated with the use of its CORAIL Hip System Femoral Stems.

From DePuy Synthes 20 Apr 2018

AYOXXA to develop multiplex immunoassay to support treatment of sepsis patients

AYOXXA Biosystems GmbH, an international biotechnology company, will develop a multiplex assay to support the treatment of sepsis patients as part of the project "SepsisData.Net.NRW - Digitized Pattern Recognition for Personalized Treatment of Sepsis Patients". The development will be based on the Company’s innovative bead-based protein analysis platform LUNARIS™.

20 Apr 2018

Podcast: KHN’s ‘What the Health?’ Nothing in health care ever goes away

Congressional Republicans have struck a decidedly different tone when talking about the Affordable Care Act, and the Democrats have introduced a new Medicare expansion bill.

20 Apr 2018

Opioid pain medications may not be safe for hemodialysis patients

A new analysis indicates that opioid pain medications may not be as safe for hemodialysis patients as recommendations suggest, and therefore, their use should be limited when possible. The analysis appears in an upcoming issue of the Clinical Journal of the American Society of Nephrology.

20 Apr 2018

Biofeedback-assisted relaxation may help children during medical procedures

A new Pain Practice study indicates that biofeedback-assisted relaxation may help manage pain and anxiety in children undergoing medical procedures.

19 Apr 2018

Maternal depression during and after pregnancy linked to poorer child neurodevelopment

Maternal depressive symptoms during pregnancy, in the first year postpartum, and in early childhood were linked with poorer child neurodevelopment in a recent Depression & Anxiety study.

19 Apr 2018

Brief bedside visual art intervention reduces pain, anxiety in cancer patients

A brief bedside visual art intervention (BVAI) facilitated by art educators improved mood and reduced pain and anxiety in a study of inpatients with haematological cancers.

19 Apr 2018

FDA approves marijuana based medication for epilepsy treatment

An advisory panel from the United States Food and Drug Administration (FDA) has recommended the approval of a novel epilepsy drug that is made up of ingredients from marijuana. The agency normally follows the recommendations of the advisory panels regarding approvals and rejections of applications of new drugs. The recommendation statement came yesterday (19th April 2018).

19 Apr 2018